# The Microvascular Function of GLP-1 and Its Analogues

> **NCT01677104** · NA · COMPLETED · sponsor: **Katarina Kos** · enrollment: 63 (estimated)

## Conditions studied

- Type 2 Diabetes
- Obesity

## Interventions

- **DRUG:** GLP-1
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01677104
- **Lead sponsor:** Katarina Kos
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 63 (ESTIMATED)
- **Last updated:** 2017-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01677104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01677104, "The Microvascular Function of GLP-1 and Its Analogues". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01677104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*